Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma
Clinical trial NCT06129955 · UNKNOWN
Trial details
- NCT number
- NCT06129955
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-11
- Primary completion
- 2025-12-31
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.